<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01184677</url>
  </required_header>
  <id_info>
    <org_study_id>ProSeal LMA 3 vs 4</org_study_id>
    <nct_id>NCT01184677</nct_id>
  </id_info>
  <brief_title>ProSeal Laryngeal Mask Airway (LMA) Size 3 vs 4 in Non-paralyzed Female Patients</brief_title>
  <official_title>Comparison of the Size 3 ProsealTM Laryngeal Mask Airway Versus Size 4 in Anaesthetized, Non-paralyzed Women: A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that ProSeal laryngeal mask airway (PLMA) of smaller size would
      reduce the incidence of mucosal injury.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ProSealTM laryngeal mask airway (PLMA; Laryngeal Mask Co. Limited, Mahe, Seychelles) is a
      laryngeal mask device with an added dorsal cuff to improve the seal and a drainage tube to
      prevent aspiration and gastric insufflations(Brain, Verghese et al. 2000).Despite its
      utility, there are complications associated with PLMA insertion such as sore throat and
      mucosal injury including oropharyngeal blood.

      The purpose of this randomized controlled study is to determine if size 3 PLMA would induce
      less mucosal damage indicated by blood on the cuff than size 4 in non-paralyzed female
      patients. The secondary objective of this study is to compare insertion time, number of
      attempts, oropharyngeal leak pressure, hemodynamic variables, and incidence of complications
      with size 3 and 4 PLMA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood on the ProSeal LMA</measure>
    <time_frame>from the start of ProSeal LMA insertion until the end of the anesthesia (around 30min , mostly less than 60min)</time_frame>
    <description>The incidence of blood on the proseal LMA upon removal of the device is assessed in each group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemodynamic variables</measure>
    <time_frame>from induction of anesthesia until immediately after the Proseal LMA insertion</time_frame>
    <description>mean arterial pressure and heart rate before and after the Proseal LMA insertion are measured.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>insertion time</measure>
    <time_frame>from grasping the Proseal LMA until an effective airway is established</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>seal pressure</measure>
    <time_frame>after successful insertion of Proseal LMA</time_frame>
    <description>oropharyngeal leak pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>other intraoperative complications</measure>
    <time_frame>from successful insertion of PLMA until the end of the anesthesia</time_frame>
    <description>airway leak, failed ventilation, regurgitation/aspiration, laryngospasm, cough/gag/retching/hiccup.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>from removal of Proseal LMA until discharge from recovery room</time_frame>
    <description>sore throat and hoarseness</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">154</enrollment>
  <condition>Oropharyngeal Injury</condition>
  <arm_group>
    <arm_group_label>Group size 4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group size 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ProSeal LMA size 3 is inserted to the patients of Group size 3.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>insertion of the ProSeal LMA (PLMA)</intervention_name>
    <description>ProSeal LMA size 3 is inserted to the patients of Group size 3.</description>
    <arm_group_label>Group size 3</arm_group_label>
    <other_name>insertion</other_name>
    <other_name>ProSeal LMA size 3</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>insertion of the PLMA</intervention_name>
    <description>ProSeal LMA size 4 is inserted to the patients of Group size 4.</description>
    <arm_group_label>Group size 4</arm_group_label>
    <other_name>insertion</other_name>
    <other_name>ProSeal LMA size 4</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female

          -  aged 18-80 yr

          -  American Society of Anesthesiologists physical status Ⅰ-Ⅱ

          -  scheduled to undergo short outpatient gynecological procedures using ProSealTM LMA
             (PLMA) for anesthesia

        Exclusion Criteria:

          -  a known or predicted difficult airway

          -  recent sore throat

          -  mouth opening less than 2.5 cm

          -  body mass index &gt; 35 kg/m2

          -  at risk of aspiration.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mihyun Kim, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2010</study_first_submitted>
  <study_first_submitted_qc>August 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 19, 2010</study_first_posted>
  <last_update_submitted>August 24, 2012</last_update_submitted>
  <last_update_submitted_qc>August 24, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Kim Mihyun</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

